Healthcare: 3 Things You Ought to Know About Gilead's Tumble

<p class="MsoNormal"><span style="color: #1f497d;">Biotech bellwether Gilead Sciences shares sagged after reporting a blockbuster quarter. Here's what investors need to know before they sell too.</span></p>